Surmodics Inc (SRDX)
26.89
+1.62
(+6.41%)
USD |
NASDAQ |
Apr 23, 16:00
26.89
0.00 (0.00%)
After-Hours: 20:00
Surmodics Cash from Financing (TTM): -1.443M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.443M |
| September 30, 2023 | 18.41M |
| June 30, 2023 | 18.28M |
| March 31, 2023 | 18.29M |
| December 31, 2022 | 19.05M |
| September 30, 2022 | -0.375M |
| June 30, 2022 | 9.356M |
| March 31, 2022 | 9.424M |
| December 31, 2021 | 10.39M |
| September 30, 2021 | 10.23M |
| June 30, 2021 | 0.358M |
| March 31, 2021 | 1.142M |
| December 31, 2020 | -0.973M |
| September 30, 2020 | -4.648M |
| June 30, 2020 | -4.362M |
| March 31, 2020 | -5.198M |
| December 31, 2019 | -3.805M |
| September 30, 2019 | -11.03M |
| June 30, 2019 | -10.97M |
| March 31, 2019 | -13.19M |
| December 31, 2018 | -14.11M |
| September 30, 2018 | -3.393M |
| June 30, 2018 | -4.35M |
| March 31, 2018 | -6.154M |
| December 31, 2017 | -5.331M |
| Date | Value |
|---|---|
| September 30, 2017 | -6.51M |
| June 30, 2017 | -5.861M |
| March 31, 2017 | -1.789M |
| December 31, 2016 | -1.705M |
| September 30, 2016 | -0.199M |
| June 30, 2016 | -0.152M |
| March 31, 2016 | -0.178M |
| December 31, 2015 | -0.174M |
| September 30, 2015 | -19.64M |
| June 30, 2015 | -19.81M |
| March 31, 2015 | -19.80M |
| December 31, 2014 | -22.91M |
| September 30, 2014 | -12.55M |
| June 30, 2014 | -20.18M |
| March 31, 2014 | -27.85M |
| December 31, 2013 | -27.55M |
| September 30, 2013 | -17.79M |
| June 30, 2013 | -65.15M |
| March 31, 2013 | -57.67M |
| December 31, 2012 | -58.56M |
| September 30, 2012 | -83.22M |
| June 30, 2012 | -27.45M |
| March 31, 2012 | -27.20M |
| December 31, 2011 | -21.29M |
| September 30, 2011 | 5.383M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-11.03M
Minimum
Sep 2019
19.05M
Maximum
Dec 2022
3.796M
Average
0.358M
Median
Jun 2021
Cash from Financing (TTM) Benchmarks
| ResMed Inc | -858.24M |
| Alphatec Holdings Inc | 356.92M |
| iRhythm Technologies Inc | 8.82M |
| OrthoPediatrics Corp | 7.301M |
| SI-BONE Inc | 90.93M |